These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8270182)

  • 21. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection and treatment of hyperprolactinemia in male infertility].
    Rogoza A; Mierzejewski W; Puzio M
    Ginekol Pol; 1994 Feb; 65(2):75-9. PubMed ID: 8070714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does treatment with bromocriptine influence the course of hyperprolactinaemia?
    Glasier AF; Hendry RA; Seth J; Baird DT
    Clin Reprod Fertil; 1987 Dec; 5(6):359-66. PubMed ID: 3505830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.
    Krysiak R; Okrzesik J; Okopien B
    Endocrine; 2015 May; 49(1):242-9. PubMed ID: 25239203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of borderline hyperprolactinemia.
    del Pozo E
    Horm Res; 1985; 22(3):204-8. PubMed ID: 4054840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology.
    Saie DJ; Sills ES
    Neuro Endocrinol Lett; 2005 Oct; 26(5):533-5. PubMed ID: 16264405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and humoral immune parameters in women with pathological hyperprolactinemia before and during treatment with bromocriptine.
    López-Karpovitch X; Larrea F; Cárdenas R; Valencia X; Piedras J; Díaz-Sánchez V; Alarcón-Segovia D
    Am J Reprod Immunol; 1994 Jan; 31(1):32-9. PubMed ID: 8166945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of hyperprolactinemia: a lower dose of bromocriptine may be effective.
    Soto-Albors CE; Randolph JF; Ying YK; Riddick DH
    Fertil Steril; 1987 Aug; 48(2):213-7. PubMed ID: 3609332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
    Touraine P; Deneux C; Plu-Bureau G; Mauvais-Jarvis P; Kuttenn F
    J Endocrinol Invest; 1998 Dec; 21(11):732-6. PubMed ID: 9972671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine.
    Newman CB; Hurley AM; Kleinberg DL
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):391-400. PubMed ID: 2576397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of beta-endorphin, cortisol, prolactin and growth hormone in depressed patients.
    Galard R; Gallart J; Arguello JM; Schwartz S; Castellanos JM; Catalán R
    Acta Psychiatr Scand; 1988 Aug; 78(2):230-3. PubMed ID: 2975911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
    Modebe O
    Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin secretion and menstrual function after long-term bromocriptine treatment.
    Rasmussen C; Bergh T; Wide L
    Fertil Steril; 1987 Oct; 48(4):550-4. PubMed ID: 3653413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Stracke H; Heinlein W; Horowski R; Schatz H
    Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macroprolactinemia in a child].
    Weill J; Petit S; Stuckens C; Descamps Y; Racadot A; Boersma A; Ponte C
    Arch Fr Pediatr; 1990 Oct; 47(8):595-6. PubMed ID: 2078111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.